Bioorganic and Medicinal Chemistry Letters p. 1705 - 1708 (2017)
Update date:2022-08-11
Topics:
Phillips, Robert S.
Anderson, Andrew D.
Gentry, Harvey G.
Güner, Osman F.
Bowen, J. Phillip
Kynurenine monooxygenase (KMO) is a potential drug target for treatment of neurodegenerative disorders such as Huntington's and Alzheimer's diseases. We have evaluated substituted kynurenines as substrates or inhibitors of KMO from Cytophaga hutchinsonii.
View MoreContact:+86-511-88790000
Address:338 North Yushan Rd, Zhenjiang, Jiangsu 212016
Zhejiang Hoshine Silicon Industry Co., Ltd.
Contact:86-573-89179966
Address:Zhapu Town, Pinghu City, Zhejiang, China
Contact:86-510-82853889
Address:Rm.3732, No.18-2,Yonghe Rd.,Wuxi,Jiangsu,214023,China
Beijing Apis Biotechnology Co., Ltd.
Contact:86-010-67856775-8551
Address:NO.4PUHUANGYU ROAD,FENTAI DISTRICT, BEIJING, CHINA
Chengdu Cogon Bio-tech Co., Ltd.
Contact:86-28-85171192
Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Doi:10.1021/acscatal.9b00739
(2019)Doi:10.1016/j.poly.2017.06.053
(2017)Doi:10.1021/ja01001a090
(1967)Doi:10.1002/cssc.201000163
(2010)Doi:10.1007/s10562-014-1315-4
(2014)Doi:10.1016/j.molcata.2011.05.014
(2011)
